Screens cell-free DNA in maternal blood for common chromosome conditions, including trisomies 21, 18 and 13 and sex chromosome abnormalities.
Used from 10 weeks of pregnancy onwards to assess the chance of common chromosome conditions such as Down, Edwards and Patau syndromes.